Marimed (MRMD) EBT (2011 - 2026)

Marimed (MRMD) has 16 years of EBT data on file, last reported at -$1.1 million in Q1 2026.

• EBT for Q1 2026 came in at -$1.1 million, up 57.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.2 million (down 30.16% YoY), and the FY2025 annual result was -$10.9 million, down 154.32% from the prior year.
• EBT grew to -$1.1 million in Q1 2026 per MRMD's latest filing, from -$7.3 million in the prior quarter.
• Over five years, EBT peaked at $7.9 million in Q1 2022 and troughed at -$9.6 million in Q4 2023.
• A 5-year average of -$174529.4 and a median of -$182000.0 in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2025: EBT jumped 258.72% in 2022, then plunged 765.33% in 2025.
• A 5-year view of EBT shows it stood at $2.8 million in 2022, then slumped by 449.55% to -$9.6 million in 2023, then jumped by 65.57% to -$3.3 million in 2024, then slumped by 120.99% to -$7.3 million in 2025, then surged by 84.77% to -$1.1 million in 2026.
• Business Quant data shows MRMD's EBT at -$1.1 million in Q1 2026, -$7.3 million in Q4 2025, and -$182000.0 in Q3 2025.